Clinical Trial Update: An Economic Study of HSK21542 Injection for Prevention of Postoperative Nausea and Vomiting [Phase 4]

View source ↗

Summary

Phase 4 trial update for HSK21542 injection evaluating its economic impact in preventing postoperative nausea and vomiting; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• HSK21542

Snippet

Sponsor: Mengchang Yang | Conditions: Nausea and Vomiting, Postoperative | Phase 4 | Status: RECRUITING